Filter Results:
(33)
Show Results For
- All HBS Web (343)
- Faculty Publications (227)
Show Results For
- All HBS Web (343)
- Faculty Publications (227)
Page 1 of 33
Results →
Sort by
- 01 Mar 2011
- News
Fixing What Ails the Drug Industry
In 2008, private investors and the National Institutes of Health plowed more than $100 billion into pharmaceutical research. And yet, “We’re not seeing the new diagnostics, treatments, preventative approaches, and cures that we might have... View Details
- 01 Mar 2007
- News
Daniel Vasella
portfolio of product lines, setting Novartis apart from its global competitors. Although initially regarded by critics as too inexperienced to lead a multinational pharmaceutical company, Vasella has triumphed. Three years ago he was... View Details
- 01 Sep 2007
- News
Alfred D. Chandler Jr. Remembered
England, and Germany by examining the 200 largest corporations in those countries. In 2001, Chandler wrote Inventing the Electronic Century: The Epic Story of the Consumer Electronics and Computer Industries, which focused on the fall of the Radio Corporation of View Details
- 24 Apr 2014
- News
A passion for the sea doubles the percent of ocean set aside for conservation
Ernesto Bertarelli (MBA 1993), an America’s Cup–winning sailor and avid scuba diver, understands the importance of protecting marine ecosystems. The former owner and CEO of the pharmaceutical and biotechnology company Serono has provided... View Details
- 01 Mar 2009
- News
A New Approach to Health-Care Reform
approach not just to insurance and reimbursement, but also to the places where medical services are delivered, the way we use technology, the way pharmaceuticals are developed, the way we educate medical professionals, and who performs... View Details
- 13 Jul 2020
- News
Locally Grown
pharmaceutical machinery sector. With the natural beauty of the Rocky Mountains as a backdrop for his career decision, Fenwick-Smith became increasingly interested in climate change and what the business community could do to make a... View Details
Keywords: April White
- 01 Jun 2012
- News
The Power of Philanthropy
When their son Joey died of cystic fibrosis in 1986 at age 12, Kathy and Joe O’Donnell (MBA 1971) vowed to fight the disease. O’Donnell, at the time the president of the Boston Concessions Group, joined with Vertex Pharmaceuticals and the... View Details
- 01 Feb 2002
- News
Health Industry Alumni Convene for Conference
and CEO of Mediconsulting, Inc., spoke about creating a better model for business collaborations between biotech and pharmaceutical firms. Said Klietmann, the conference's biotechnology chair and a lecturer in pathology at Harvard Medical... View Details
- 01 Dec 2004
- News
Finding a Balance
Do the rules of business change when a company’s product holds the power of life or death over its customers? That’s a question students must consider when discussing “Cipla,” a case about a $325 million Indian pharmaceutical company that... View Details
- 01 Sep 2006
- News
Gift of Gab
then delivered a prepared talk on a topic of their choice. Subjects ranged from the pharmaceutical industry to the relative merits of cats vs. dogs, while Kim’s presentation took a humorous yet thoughtful approach to lessons learned in... View Details
- 01 Dec 2010
- News
How to Survive Past Start-up
Cenedella tried several other ideas for job-industry companies before he came up with the idea for TheLadders. Michel spent years searching for the right business idea — even helping to start a pharmaceutical industry computer firm —... View Details
- 01 Dec 2013
- News
Your Own Medicine
to the trade group Pharmaceutical Research and Manufacturers of America (PhRMA), only one of 5,000 to 10,000 experimental compounds make it to FDA approval, and just 2 of the 10 that get that approval... View Details
- 03 Nov 2016
- News
17 Ventures Join the Pagliuca Harvard Life Lab
Institute/HMS Nix – HBS, SEAS, Blavatnik Fellow PathoVax – HMS Piper Therapeutics – College, HBS Riparian Pharmaceuticals – College, SEAS Suono Bio – HMS UnNamed – HMS UrSure Inc. – HKS Vaxess Technologies, Inc. HBS, SEAS, HKS, HLS... View Details
- 24 Apr 2014
- News
Giving hope and inspiration to cancer patients around the globe
Every new day is a good day for Kathryn E. Giusti (MBA 1985) since that morning in 1996 when her oncologist told her to get her affairs in order because she had a rare blood cancer, with three years to live. Leveraging her past experience as a View Details
- 01 Feb 2002
- News
Telling the Electronic Century's Unfinished Story
and pharmaceutical industries. But the differences between those pairs of sectors were just too great. So the second book will examine this question: Why were the Japanese chemical and pharmaceutical... View Details
- 01 Sep 2012
- News
What’s the Big Idea?
international divisions. “Goldman Sachs in New York is different from Goldman Sachs in Asia,” he observes, adding that the same is true for conglomerates operating in industries as different as pharmaceuticals and aircraft engines.... View Details
- 01 Sep 2011
- News
MBA 101: HBS Commencements Pass the Century Mark
pharmaceutical executive at the time of her diagnosis with multiple myeloma, an incurable, rare, and little-researched blood cancer, Giusti went on to found the Multiple Myeloma Research Foundation and the Multiple Myeloma Research... View Details
- 01 Dec 2003
- News
The Next Big Thing
life-sciences center of the world, by virtue of its unsurpassed “cluster” of world-renowned universities and teaching hospitals; medical-device, biotech, and pharmaceutical companies; financial firms; and skilled workers. “The leadership... View Details
- 01 Sep 2006
- News
HBS Student Battles ALS
people every year, is not a high priority for either the public or pharmaceutical companies. To stimulate novel treatment ideas and to raise the venture funding needed to get those ideas to market, he launched two organizations. One is... View Details
- 01 Mar 2003
- News
Inside the Revolution
care and life sciences issues, with the lion’s share focusing on the biotech and pharmaceutical industries. More than twenty HBS professors from different disciplines have contributed to this effort, which Pisano says is analogous to the... View Details